Shares of Select Medical Holdings Corporation (NYSE:SEM – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six analysts that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $17.80.
Several brokerages recently issued reports on SEM. Weiss Ratings restated a “sell (d+)” rating on shares of Select Medical in a research report on Wednesday, October 8th. Royal Bank Of Canada lifted their price target on shares of Select Medical from $16.00 to $20.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 8th. Bank of America reduced their price objective on Select Medical from $18.00 to $15.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Wall Street Zen upgraded Select Medical from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Finally, Mizuho set a $17.00 price target on Select Medical in a research report on Monday, November 3rd.
Get Our Latest Analysis on SEM
Hedge Funds Weigh In On Select Medical
Select Medical Stock Down 0.3%
Select Medical stock opened at $14.99 on Monday. Select Medical has a one year low of $11.65 and a one year high of $20.83. The stock has a fifty day moving average of $14.20 and a 200 day moving average of $13.87. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.09 and a current ratio of 1.09. The stock has a market cap of $1.86 billion, a PE ratio of 17.43, a price-to-earnings-growth ratio of 0.55 and a beta of 1.28.
Select Medical (NYSE:SEM – Get Free Report) last announced its earnings results on Thursday, October 30th. The health services provider reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.05. Select Medical had a return on equity of 7.41% and a net margin of 2.05%.The business had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same period last year, the firm posted $0.43 earnings per share. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. As a group, sell-side analysts predict that Select Medical will post 1.17 EPS for the current year.
Select Medical Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, November 25th. Investors of record on Wednesday, November 12th were issued a $0.0625 dividend. This represents a $0.25 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend was Wednesday, November 12th. Select Medical’s dividend payout ratio is currently 29.07%.
About Select Medical
Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.
Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.
Featured Articles
- Five stocks we like better than Select Medical
- How Long Will $1M Last in Retirement?
- GOLD ALERT
- Bitcoin is down but your income is about to explode
- This 40-year cover-up is ending
- How the Rich Retire
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.
